Not Yet Recruiting INTERVENTIONAL NCT07561268
Stenting Of Symptomatic Cerebral siNus stenosIs With the laserCut Self-expanding SILANCE Stent (SONIC)
Sponsor: Acandis GmbH
Conditions
Idiopathic Intracranial Hypertension (IIH)
Interventions
SILANCE Stent Implantation
Updated 1 time since 2026 Last updated: Apr 28, 2026 Started: Sep 1, 2026 Primary completion: Oct 1, 2028 Completion: Oct 1, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07561268, this observational or N/A phase trial focuses on Idiopathic Intracranial Hypertension (IIH) and remains actively recruiting participants. Sponsored by Acandis GmbH, it has been updated 1 time since 2026, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
1 version recorded Not Yet Recruiting
[daily]
Eligibility Summary
The objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.
Contact Information
Sponsor contact:
- Acandis GmbH
Data source: ClinicalTrials.gov
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.